1. C-X-C-Chemokine-Receptor-Type-4 Inhibitor AMD3100 Attenuates Pulmonary Inflammation and Fibrosis in Silicotic Mice
   Qixian Sun et al, 2022, Journal of Inflammation Research CrossRef
2. Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
   Xinyu Li et al, 2022, Frontiers in Molecular Biosciences CrossRef
3. Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
   Maurizio Cutolo et al, 2021, Arthritis Research & Therapy CrossRef
4. CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
   Kayode Komolafe et al, 2022, International Journal of Inflammation CrossRef
5. Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury
   Fei Sun et al, 2024, International Journal of Clinical Practice CrossRef
6. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
   Frank W. Pun et al, 2022, Aging CrossRef
7. Pericytes: The lung-forgotten cell type
   Annelise T. Garrison et al, 2023, Frontiers in Physiology CrossRef